Wealthfront’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$1.37M Buy
15,323
+3,805
+33% +$336K 0.01% 195
2018
Q2
$915K Sell
11,518
-1,865
-14% -$155K 0.01% 269
2018
Q1
$1.19M Sell
13,383
-7,582
-36% -$728K 0.01% 221
2017
Q4
$2.19M Sell
20,965
-16,141
-43% -$1.82M 0.02% 113
2017
Q3
$5.41M Buy
37,106
+4,147
+13% +$565K 0.07% 50
2017
Q2
$4.28M Sell
32,959
-157
-0.5% -$19.2K 0.06% 53
2017
Q1
$4.12M Buy
33,116
+6,581
+25% +$788K 0.07% 51
2016
Q4
$3.07M Buy
26,535
+8,608
+48% +$959K 0.07% 52
2016
Q3
$1.87M Buy
17,927
+3,721
+26% +$403K 0.04% 69
2016
Q2
$1.4M Buy
14,206
+2,346
+20% +$243K 0.04% 78
2016
Q1
$1.19M Sell
11,860
-4,052
-25% -$417K 0.04% 82
2015
Q4
$1.91M Buy
15,912
+304
+2% +$35.2K 0.07% 54
2015
Q3
$1.69M Buy
15,608
+5,390
+53% +$669K 0.07% 58
2015
Q2
$1.18M Buy
10,218
+823
+9% +$94.1K 0.05% 48
2015
Q1
$1.08M Buy
9,395
+587
+7% +$70.1K 0.05% 39
2014
Q4
$985K Buy
8,808
+2,362
+37% +$249K 0.06% 38
2014
Q3
$611K Buy
6,446
+781
+14% +$70.5K 0.04% 50
2014
Q2
$511K Buy
5,665
+4,897
+638% +$372K 0.04% 40
2014
Q1
$56K Buy
+768
New +$60.8K 0.01% 240

Other funds holding CELG

Wealthfront's CELG Position: Q3 2018 in Review

Wealthfront increased its Celgene Corp (CELG) stake by 33% in Q3 2018, buying an estimated $336K and bringing the position to 15,323 shares worth $1.37M. The position accounts for 0.01% of the portfolio, ranked #195.

Wealthfront first reported a position in CELG in Q1 2014 and has held it in 19 quarters since. The position peaked at $5.41M in Q3 2017. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Wealthfront held 15,323 shares of Celgene Corp worth $1.37M as of Q3 2018.
  • Wealthfront bought 3,805 Celgene Corp shares in Q3 2018, an estimated $336K.
  • Celgene Corp made up 0.01% of Wealthfront's portfolio in Q3 2018, its #195 holding.
  • Wealthfront first reported a position in Celgene Corp in Q1 2014 and has held it in 19 quarters since.
  • Wealthfront's Celgene Corp position peaked at $5.41M in Q3 2017.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Wealthfront's 13F filing for Q3 2018, filed 13 Nov 2018.